The first FDA-Approved oral suspension form of mercaptopurine, PURIXAN offers flexibility and accuracy of dosing, consistent absorption and is a palatable alternative to current mercaptopurine therapies.¹
The first FDA-Approved oral suspension form of mercaptopurine, PURIXAN offers flexibility and accuracy of dosing, consistent absorption and is a palatable alternative to current mercaptopurine therapies.¹
¹PURIXAN (mercaptopurine) oral suspension [package insert]. Franklin, TN: Rare Disease Therapeutics, Inc.; April 2020.